ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Icon Clinical Research (U.K.) NO. 2 Limited

Icon Clinical Research (U.K.) NO. 2 Limited is an active company incorporated on 30 July 2013 with the registered office located in Reading, Berkshire. Icon Clinical Research (U.K.) NO. 2 Limited was registered 12 years ago.
Status
Active
Active since 11 years ago
Company No
08630390
Private limited company
Age
12 years
Incorporated 30 July 2013
Size
Small
Turnover is under £15M
Balance sheet is under £7.5M
Under 50 employees
Confirmation
Submitted
Dated 15 March 2025 (7 months ago)
Next confirmation dated 15 March 2026
Due by 29 March 2026 (4 months remaining)
Last change occurred 3 years ago
Accounts
Submitted
For period 1 Jan31 Dec 2023 (12 months)
Accounts type is Full
Next accounts for period 31 December 2024
Due by 31 December 2025 (1 month remaining)
Address
3rd Floor, North & South Wings 100 Longwater Avenue
Green Park
Reading
Berkshire
RG2 6GP
United Kingdom
Address changed on 2 Jun 2025 (5 months ago)
Previous address was 500 South Oak Way Green Park Reading RG2 6AD England
Telephone
02078371693
Email
Available in Endole App
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in Ireland • Born in Dec 1966
Director • Irish • Lives in Ireland • Born in Sep 1978
Secretary
Icon Clinical Research (U.K.) Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Aptiv Solutions (UK) Ltd
Simon Holmes is a mutual person.
Active
Icon Clinical Research (U.K.) NO. 3 Limited
Simon Holmes is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2014–2023)
Period Ended
31 Dec 2023
For period 31 Dec31 Dec 2023
Traded for 12 months
Cash in Bank
£100.83K
Decreased by £831.6K (-89%)
Turnover
£2.39M
Decreased by £190.92K (-7%)
Employees
13
Decreased by 1 (-7%)
Total Assets
£4.3M
Decreased by £165.44K (-4%)
Total Liabilities
-£683.73K
Decreased by £269.53K (-28%)
Net Assets
£3.62M
Increased by £104.09K (+3%)
Debt Ratio (%)
16%
Decreased by 5.45% (-26%)
Latest Activity
Registered Address Changed
5 Months Ago on 2 Jun 2025
Icon Clinical Research (U.K.) Limited (PSC) Appointed
5 Months Ago on 31 May 2025
Icon Clinical Research (U.K.) No. 3 Limited (PSC) Resigned
5 Months Ago on 31 May 2025
Confirmation Submitted
7 Months Ago on 21 Mar 2025
Full Accounts Submitted
11 Months Ago on 4 Dec 2024
Confirmation Submitted
1 Year 7 Months Ago on 15 Mar 2024
Full Accounts Submitted
1 Year 10 Months Ago on 4 Jan 2024
Confirmation Submitted
2 Years 7 Months Ago on 23 Mar 2023
Full Accounts Submitted
2 Years 10 Months Ago on 5 Jan 2023
Michael Gleeson Resigned
3 Years Ago on 21 Oct 2022
Get Credit Report
Discover Icon Clinical Research (U.K.) NO. 2 Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Registered office address changed from 500 South Oak Way Green Park Reading RG2 6AD England to 3rd Floor, North & South Wings 100 Longwater Avenue Green Park Reading Berkshire RG2 6GP on 2 June 2025
Submitted on 2 Jun 2025
Notification of Icon Clinical Research (U.K.) Limited as a person with significant control on 31 May 2025
Submitted on 2 Jun 2025
Cessation of Icon Clinical Research (U.K.) No. 3 Limited as a person with significant control on 31 May 2025
Submitted on 2 Jun 2025
Confirmation statement made on 15 March 2025 with no updates
Submitted on 21 Mar 2025
Full accounts made up to 31 December 2023
Submitted on 4 Dec 2024
Confirmation statement made on 15 March 2024 with no updates
Submitted on 15 Mar 2024
Full accounts made up to 31 December 2022
Submitted on 4 Jan 2024
Confirmation statement made on 18 March 2023 with no updates
Submitted on 23 Mar 2023
Full accounts made up to 31 December 2021
Submitted on 5 Jan 2023
Termination of appointment of Michael Gleeson as a director on 21 October 2022
Submitted on 6 Dec 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year